L Scott Burrows

Affiliations

  • Chief Financial Officer at Spyre Therapeutics Inc. (SYRE), 2024-09-05
  • Chief Financial Officer at Arcutis Biotherapeutics Inc. (ARQT), 2023-03-08
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SYRE $28.17 18,531 Officer 116,422 2024-09-03 Filing
ARQT $15.26 291 Officer 59,115 2023-03-06 Filing
ARQT $16.52 18 Officer 38,406 2023-03-02 Filing
ARQT $15.82 1,416 Officer 38,424 2023-03-02 Filing
ARQT $16.17 416 Officer 39,840 2023-02-28 Filing